Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Severance hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
University of Missouri - Columbia dept. of Emergency Medicine, Columbia, Missouri, United States
Telemark Hospital, Skien, Telemark, Norway
Service of Anesthesiology; Geneva University Hospital, Geneva, Switzerland
Helsinki University Central Hospital,Meilahti hospital,Endoscopy unit, Helsinki, Uusimaa, Finland
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
The University of Chicago Medical Center, Chicago, Illinois, United States
Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong, China
University of Rochester, Rochester, New York, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.